We have located links that may give you full text access.
Risk of Immune-related Diseases in Childhood after Intrapartum Antibiotic Exposure.
American Journal of Obstetrics and Gynecology 2024 Februrary 17
BACKGROUND: Intrapartum antibiotic prophylaxis is effective in preventing early-onset group B streptococcal disease in newborn infants, but it influences gut microbiota development. Gut microbiota composition is in turn associated with immune-related diseases in childhood.
OBJECTIVE: We hypothesized that intrapartum antibiotic exposure is associated with immune-related diseases in childhood.
STUDY DESIGN: We conducted a population-based cohort study of vaginally delivered children. We retrieved data on intrapartum antibiotic exposure from structured electronic medical records and obtained outcome data on childhood autoimmune, allergic, and obstructive airway diseases from comprehensive national registers. We used Cox regression analysis adjusted for maternal and neonatal covariates and regarded death as a competing risk in the analyses.
RESULTS: Study population comprised 45 575 vaginally born children, of whom 9733 (21%) had been exposed to intrapartum antibiotics. Intrapartum antibiotic exposure was associated with autoimmune disease diagnosis (adjusted hazard ratio 1.28 [95% CI 1.02- 1.62]) corresponding to 22% (95% CI 6% - 39%) as a theoretical population-attributable fraction. Intrapartum antibiotic exposure was not associated with diagnoses of allergic (adjusted hazard ratio 1.08 [95% CI 0.97 - 1.20]) or obstructive airway diseases (adjusted hazard ratio 1.04 [95% CI 0.96 - 1.14]).
CONCLUSIONS: Intrapartum antibiotic exposure may be associated with an increased risk of autoimmune diseases in childhood. This finding supports the efforts to develop more specific group B streptococcal disease prevention strategies in the future.
OBJECTIVE: We hypothesized that intrapartum antibiotic exposure is associated with immune-related diseases in childhood.
STUDY DESIGN: We conducted a population-based cohort study of vaginally delivered children. We retrieved data on intrapartum antibiotic exposure from structured electronic medical records and obtained outcome data on childhood autoimmune, allergic, and obstructive airway diseases from comprehensive national registers. We used Cox regression analysis adjusted for maternal and neonatal covariates and regarded death as a competing risk in the analyses.
RESULTS: Study population comprised 45 575 vaginally born children, of whom 9733 (21%) had been exposed to intrapartum antibiotics. Intrapartum antibiotic exposure was associated with autoimmune disease diagnosis (adjusted hazard ratio 1.28 [95% CI 1.02- 1.62]) corresponding to 22% (95% CI 6% - 39%) as a theoretical population-attributable fraction. Intrapartum antibiotic exposure was not associated with diagnoses of allergic (adjusted hazard ratio 1.08 [95% CI 0.97 - 1.20]) or obstructive airway diseases (adjusted hazard ratio 1.04 [95% CI 0.96 - 1.14]).
CONCLUSIONS: Intrapartum antibiotic exposure may be associated with an increased risk of autoimmune diseases in childhood. This finding supports the efforts to develop more specific group B streptococcal disease prevention strategies in the future.
Full text links
Related Resources
Trending Papers
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation 2024 May 9
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app